BMO Capital Upgrades Ironwood Pharmaceuticals (IRWD) to Outperform

January 10, 2014 7:47 AM EST
Get Alerts IRWD Hot Sheet
Price: $12.38 +1.48%

Rating Summary:
    8 Buy, 11 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 19 | Down: 15 | New: 31
Trade IRWD Now!
Join SI Premium – FREE
BMO Capital upgraded Ironwood Pharmaceuticals (NASDAQ: IRWD) from Market Perform to Outperform with a price target of $16.00 (from $15.00).

For an analyst ratings summary and ratings history on Ironwood Pharmaceuticals click here. For more ratings news on Ironwood Pharmaceuticals click here.

Shares of Ironwood Pharmaceuticals closed at $12.39 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Upgrades

Related Entities

BMO Capital

Add Your Comment